Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05611814 · ClinicalTrials.gov registry record · NA
Preliminary Evaluation of an Osteopathic Manipulative Treatment (OMT) to Prevent Motion Sickness Symptoms
A NA study, sponsored by United States Army Aeromedical Research Laboratory.
- Completed
- Registry status
- NA
- Development phase
- 12
- Enrollment target
NCT05611814 is a NA study that has completed, run by United States Army Aeromedical Research Laboratory. The registered enrollment target is 12 participants.
The verdict
NCT05611814, a NA study, has completed, sponsored by United States Army Aeromedical Research Laboratory.
- COMPLETED
- Registry status
- NA
- Development phase
- 12 participants
- Enrollment target
Study Summary
Motion sickness directly impacts the readiness of the Army's aviation units. Severe motion sickness results in the dismissal of pilot and air crew candidates during initial training, while minor to moderate symptoms can be distracting during flight. The current medications on the market that target motion sickness symptoms are prohibited for use before flight. Osteopathic Manipulative Techniques are a low to no cost option, which lacks side effects, that allows Doctor of Osteopathic Medicine flight surgeons the opportunity to treat crew members without the use of pharmaceuticals. If effective, these techniques could be used to ensure aircrew readiness. Given the paucity of research on such a technique, a small, pilot study was conducted to demonstrate potential for such an approach.
Interventions
- OTHER Sham treatment
- OTHER Osteopathic Manipulative Treatment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2022-09-24 |
| Est. Completion | 2022-09-24 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05611814
The ClinicalTrials.gov registry entry for NCT05611814 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is United States Army Aeromedical Research Laboratory, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Sham treatment is the first listed.
NCT05611814 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05611814 about?
NCT05611814 is a clinical study titled "Preliminary Evaluation of an Osteopathic Manipulative Treatment (OMT) to Prevent Motion Sickness Symptoms". Motion sickness directly impacts the readiness of the Army's aviation units. Severe motion sickness results in the dismissal of pilot and air crew candidates during initial training, while minor to moderate symptoms can be distracting during flight. The current medications on the market that target ...
What is the current status of trial NCT05611814?
This trial is currently completed. It is a NA study. The enrollment target is 12 participants. The study started on 2022-09-24. Estimated completion is 2022-09-24.
What interventions are being tested in trial NCT05611814?
The interventions under investigation include: Sham treatment (OTHER), Osteopathic Manipulative Treatment (OTHER).
Who is sponsoring clinical trial NCT05611814?
This trial is sponsored by United States Army Aeromedical Research Laboratory, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.